13239E
Centrisart® I centrifugal ultrafiltration unit
MWCO 10 kDa
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
UNSPSC Code:
41104916
NACRES:
NB.24
Recommended Products
material
polystyrene housing
polystyrene outer tube
polysulfone membrane
sterility
non-sterile
packaging
pack of 12 tubes
manufacturer/tradename
Sartorius 13239E
parameter
2000 × g max. force (fixed angle)
2500 × g max. force (swinging bucket)
filtration area
0.79 cm2
outer sample tube W × L
14 mm × 93 mm
tube size
~15 mL
working volume × concentrate volume
2.5 mL × 100
pore size
10 kDa MWCO
Looking for similar products? Visit Product Comparison Guide
Related Categories
General description
- Centrisart® I centrifugal ultrafiltration unit is ideal for the separation of small-volume proteins from low molecular weight substances in biological samples.
- The unit works in the direction opposite to centrifugal force which prevents premature filter blockage.
- This versatile device is utilized in both fixed-angle or swinging-bucket rotors that hold standard 15 mL tubes.
- The product is collected in the easily accessible floater insert tube.
Application
- Protein removal from blood samples
- Drug binding studies
- Cleaning of liposomes (cell lysates)
Legal Information
Centrisart is a registered trademark of Sartorius Stedim Biotech GmbH
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Agnieszka Smolinska et al.
Analytical and bioanalytical chemistry, 403(4), 947-959 (2012-03-08)
Because cerebrospinal fluid (CSF) is the biofluid which interacts most closely with the central nervous system, it holds promise as a reporter of neurological disease, for example multiple sclerosis (MScl). To characterize the metabolomics profile of neuroinflammatory aspects of this
Wenyi Zheng et al.
Scientific reports, 10(1), 1274-1274 (2020-01-29)
Selenocompounds (SeCs) are promising therapeutic agents for a wide range of diseases including cancer. The treatment results are heterogeneous and dependent on both the chemical species and the concentration of SeCs. Moreover, the mechanisms of action are poorly revealed, which most
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service